Virtual reality tested as pain relief for advanced breast cancer
NCT ID NCT07497451
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether virtual reality (VR) guided imagery can reduce pain in people with stage III or IV breast cancer. Ninety participants will be split into three groups: one using immersive VR (headset), one using non-immersive VR (computer screen), and a control group receiving standard care. Pain levels will be measured before and after a single 45-minute session to see if VR provides extra relief.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- virtual reality guided imagery (non-immersive and immersive)
- What this could lead to
- If it works, this could offer a drug-free way to help manage cancer pain alongside standard treatments.
- What could go wrong
- This is a small, early-stage study (90 people) that only measures pain right after a single session. It may not show lasting benefits or work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria * Patients diagnosed with advanced stage of breast cancer; based on pathological analysis (this Data from electronic medical record system). * Undergoing treatment in the selected Hospital * Age group \>18 years of age (Adult) * Hospitalized patient at the selected study setting * Available at the time of data collection; the minimum expected admission time should be no less than 5 days, as the intervention is planned to last for 5 days. * Able to sign the consent form. * Willing to comply with study procedures and instructions. * has cancer pain. Exclusion Criteria * Individuals who are experiencing difficulties in their ability to hear or have a complete loss of hearing. * Individuals who suffer from extreme visual impairment or complete loss of vision. * Not willing to participate in the study. * Patient with Glasgow coma scale \< 15 * Individuals who experience persistent and uncontrollable feelings of nausea, vomiting, or dizziness, individuals with a background of motion sickness (Rational for exclusion: According to previous studies, the utilization of VR intervention may have adverse effects, including Dizziness, nausea, vomiting, and motion sickness (Simón-Vicente et al., 2022).As a result, in order to prevent the exacerbation of these symptoms among patients, they will not be included in the VR intervention) * Individuals with a history of seizures or epilepsy (Rational for exclusion: Individuals diagnosed with epilepsy have frequently been excluded from the participation in virtual reality (VR) research due to the concern that engaging with VR technology could potentially induce seizures in those who have photosensitive epilepsy (Gray et al., 2023) * A patient who has an injury at their eyes, face, or neck that hinders their ability to comfortably utilize virtual reality (VR) hardware or software or poses a safety risk when using the hardware (such as having open sores, wounds, or a skin rash on their face).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advanced breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Middle east university
Amman, 11831, Jordan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an oral drug replace injections for advanced breast cancer?
- Two-Drug HER2 attack vs one: which First-Line strategy helps advanced breast cancer patients live longer?
- Can a video game teach cancer patients to tame their pain?
- Can a new drug combo outsmart breast cancer that resists current therapy?
- Can a new tracer make tumors light up on scans?
- Can fasting and exercise beat cancer fatigue?